Abstract：
UNASSIGNED: Colorectal cancer is one of the most common digestive tract tumors.
UNASSIGNED: To evaluate the feasibility and safety of laparoscopic colorectal cancer surgery.
UNASSIGNED: This study retrospectively analyzed early postoperative clinical data of 48 patients with colorectal cancer treated in our hospital between 2015 and 2021, of which 21 underwent laparoscopic colorectal surgery, and 27 underwent laparotomy. There was no significant difference in clinical data. Patients were included if they had colorectal cancer (confirmed by colonoscopy and biopsy pathological examination before surgery), were evaluated for possible radical surgery before surgery, and had no intestinal obstruction, tumor invasion of adjacent organs (by digital rectal examination and preoperative abdominal color Doppler ultrasound, CT confirmed) and no other history of abdominal surgery. Using the method of clinical control study, operation time, intraoperative blood loss, postoperative general condition, surgical lymph node removal (postoperative pathology), surgical complications, gastrointestinal function recovery, surgical before and after blood glucose, body temperature, white blood cells, pain visual analog scale (VAS) and other conditions were compared and analyzed to determine feasibility and safety of laparoscopic surgery for colorectal cancer.
UNASSIGNED: Colorectal cancer was successfully removed by laparoscopic radical resection without any significant problems or surgical fatalities. Age, gender, tumor location, stage, and duration of surgery did not differ between laparoscopic and laparotomy operations. Compared to laparotomy, postoperative eating, bowel movements, and blood sugar levels improved. Variations in the length of surgically removed specimens after VAS measurements revealed open and laparoscopic operations. The overall lymph node count was 10.8 ± 1.6, with no variation between the two techniques.
UNASSIGNED: Laparoscopic colorectal cancer radical surgery is safe and feasible. Also, it has the advantages of minimally invasive surgery. Laparoscopic colorectal cancer radical surgery can comply with the principles of oncology revolutionary.
UNASSIGNED: To evaluate the feasibility and safety of laparoscopic colorectal cancer surgery.
UNASSIGNED: This study retrospectively analyzed early postoperative clinical data of 48 patients with colorectal cancer treated in our hospital between 2015 and 2021, of which 21 underwent laparoscopic colorectal surgery, and 27 underwent laparotomy. There was no significant difference in clinical data. Patients were included if they had colorectal cancer (confirmed by colonoscopy and biopsy pathological examination before surgery), were evaluated for possible radical surgery before surgery, and had no intestinal obstruction, tumor invasion of adjacent organs (by digital rectal examination and preoperative abdominal color Doppler ultrasound, CT confirmed) and no other history of abdominal surgery. Using the method of clinical control study, operation time, intraoperative blood loss, postoperative general condition, surgical lymph node removal (postoperative pathology), surgical complications, gastrointestinal function recovery, surgical before and after blood glucose, body temperature, white blood cells, pain visual analog scale (VAS) and other conditions were compared and analyzed to determine feasibility and safety of laparoscopic surgery for colorectal cancer.
UNASSIGNED: Colorectal cancer was successfully removed by laparoscopic radical resection without any significant problems or surgical fatalities. Age, gender, tumor location, stage, and duration of surgery did not differ between laparoscopic and laparotomy operations. Compared to laparotomy, postoperative eating, bowel movements, and blood sugar levels improved. Variations in the length of surgically removed specimens after VAS measurements revealed open and laparoscopic operations. The overall lymph node count was 10.8 ± 1.6, with no variation between the two techniques.
UNASSIGNED: Laparoscopic colorectal cancer radical surgery is safe and feasible. Also, it has the advantages of minimally invasive surgery. Laparoscopic colorectal cancer radical surgery can comply with the principles of oncology revolutionary.
摘要：
■结直肠癌是最常见的消化道肿瘤之一。
■评估腹腔镜结直肠癌手术的可行性和安全性。
■本研究回顾性分析2015-2021年我院收治的48例结直肠癌患者术后早期临床资料，其中21例接受腹腔镜结直肠手术治疗，27人接受了剖腹手术。临床资料差异无统计学意义。如果患者患有结直肠癌（手术前经结肠镜检查和活检病理检查证实），在手术前评估可能的根治性手术，没有肠梗阻,肿瘤侵犯邻近器官(通过直肠指检和术前腹部彩色多普勒超声，CT证实）且无其他腹部手术史。采用临床对照研究的方法,操作时间,术中失血,术后一般情况,手术切除淋巴结（术后病理），手术并发症,胃肠功能恢复,手术前后血糖，体温,白细胞,疼痛视觉模拟量表(VAS)等情况进行对比分析,确定腹腔镜结直肠癌手术的可行性和安全性。
■结直肠癌通过腹腔镜根治术成功切除，没有任何重大问题或手术死亡。年龄,性别,肿瘤位置,舞台,腹腔镜和开腹手术的手术时间没有差异.与剖腹手术相比，术后进食，排便,血糖水平改善。VAS测量后，手术切除的标本长度的变化揭示了开放和腹腔镜手术。总淋巴结计数为10.8±1.6，两种技术之间没有差异。
■腹腔镜结直肠癌根治术是安全可行的。此外，具有微创手术的优点。腹腔镜结直肠癌根治术能符合肿瘤学革命性的原则。
■评估腹腔镜结直肠癌手术的可行性和安全性。
■本研究回顾性分析2015-2021年我院收治的48例结直肠癌患者术后早期临床资料，其中21例接受腹腔镜结直肠手术治疗，27人接受了剖腹手术。临床资料差异无统计学意义。如果患者患有结直肠癌（手术前经结肠镜检查和活检病理检查证实），在手术前评估可能的根治性手术，没有肠梗阻,肿瘤侵犯邻近器官(通过直肠指检和术前腹部彩色多普勒超声，CT证实）且无其他腹部手术史。采用临床对照研究的方法,操作时间,术中失血,术后一般情况,手术切除淋巴结（术后病理），手术并发症,胃肠功能恢复,手术前后血糖，体温,白细胞,疼痛视觉模拟量表(VAS)等情况进行对比分析,确定腹腔镜结直肠癌手术的可行性和安全性。
■结直肠癌通过腹腔镜根治术成功切除，没有任何重大问题或手术死亡。年龄,性别,肿瘤位置,舞台,腹腔镜和开腹手术的手术时间没有差异.与剖腹手术相比，术后进食，排便,血糖水平改善。VAS测量后，手术切除的标本长度的变化揭示了开放和腹腔镜手术。总淋巴结计数为10.8±1.6，两种技术之间没有差异。
■腹腔镜结直肠癌根治术是安全可行的。此外，具有微创手术的优点。腹腔镜结直肠癌根治术能符合肿瘤学革命性的原则。
